In the spring, the AMA issued a statement warning against the use of hydroxychloroquine as a COVID-19 therapeutic. “Physicians, pharmacists, patients and policymakers must understand that these medications have dangerous side effects, that may lead to patient harm, including fatal cardiac arrhythmias.” Before the election, the American Medical Association was considering rescinding their previous statement. Unfortunately, they chose to stick to their original position.
But why was the AMA considering rescinding their previous statement?
It’s a good question, but perhaps the more important question is why didn’t the AMA rescind their previous statement? The science says they should have.
Actually, the science says they should never have discouraged the use of hydroxychloroquine in the first place. Hydroxychloroquine is a decades-old malaria drug. The side effects are well documented. For many months now there have been ample studies showing it was safe to use and significantly reduced COVID-19 mortality rates, but the media relentlessly covered bogus studies that suggested hydroxychloroquine was linked to higher mortality rates and other dangerous side effects instead.
There are currently over a hundred studies on the efficacy of hydroxychloroquine in treating COVID-19 (most of them peer-reviewed) that overwhelmingly show positive results, particularly when administered early. For example, a study published a month ago out of Saudi Arabia found that “Early intervention with HCQ-based therapy in patients with mild to moderate symptoms at presentation is associated with lower adverse clinical outcomes among COVID-19 patients, including hospital admissions, ICU admission, and/or death.”
Another study published in early September of nursing home patients found that patients not treated with hydroxychloroquine had a mortality rate more than five times higher than those who were treated with hydroxychloroquine and azithromycin. Back in July, a large-scale, peer-reviewed study conducted by the Henry Ford Health System concluded that hydroxychloroquine successfully lowered mortality rates for hospitalized coronavirus patients.
Back in April, it was noted that countries with high rates of malaria have significantly lower COVID-19 mortality rates. Since hydroxychloroquine is a decades-old anti-malaria drug, the connection between hydroxychloroquine and lower rates of COVID-19 mortality was impossible to ignore… except by the anti-Trump media who wanted Joe Biden elected president. One analysis suggests that over 840,000 lives worldwide were lost because hydroxychloroquine was not being widely used as a therapeutic.